Patents Represented by Attorney Yonggang Ji
  • Patent number: 7567346
    Abstract: A system and method for multimode imaging of at least one sample is disclosed. The system includes at least one light source; an optical system selected responsive to a mode of operation of the imaging system; and a detector capable of selective reading of pixels. The at least one sample is moved elative to the optical system using a sample movement technique selected from the group consisting of step sample moving and continuous sample moving. The method includes the steps of (1) selecting a mode of operation for the imaging system; (2) transmitting light from at least one light source through an optical system selected in response to the mode of operation for the imaging system; (3) moving the at least one sample relative to the optical system using a sample movement technique selected from the group consisting of step sample moving and continuous sample moving; and (4) selectively reading pixels with a detector.
    Type: Grant
    Filed: March 1, 2006
    Date of Patent: July 28, 2009
    Assignee: General Electric Company
    Inventors: Pavel A. Fomitchov, Eugene Barash, Ahmad Yetka, Joseph Masino, III
  • Patent number: 7566395
    Abstract: The present invention relates to automated chromatography systems and software for controlling such automated systems for optimising the purification of a protein from a sample. The software is adapted to monitor the signal from a detector in the system, determine two signal parameters and to control the components of the system depending on the actual values of the two signal parameters.
    Type: Grant
    Filed: December 10, 2004
    Date of Patent: July 28, 2009
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Elsa Lundblad, Lotta Hedkvist, Henrik Sundqvist, Markus Galin, Thomas Pless, Jill Simon
  • Patent number: 7563587
    Abstract: The present invention relates to a method for analysing a cell sample for cell surface-bound or intracellularly bound analytes by providing an array of immobilised specific binding agents for a set of different ligands, where each ligand is specific to a respective cell surface-bound or intracellularly bound analyte, and using the array and the set of ligands in an inhibition type or a direct type assay format to determine cell surface-bound or intracellularly bound analytes in the cell sample. The invention also relates to assay kits for cell characterization.
    Type: Grant
    Filed: March 31, 2004
    Date of Patent: July 21, 2009
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Robert Karlsson, Pascale Richalet-Secordel
  • Patent number: 7560254
    Abstract: A method of characterizing a nucleic acid sample is provided that includes the steps of: (a) conducting a DNA polymerase reaction that includes the reaction of a template, an allele specific primer, at least one terminal phosphate-labeled nucleotide, DNA polymerase, and optionally an enzyme having 3??5? exonuclease activity when the primer is non-hydrolyzable, which reaction results in the production of labeled polyphosphate; (b) permitting the labeled polyphosphate to react with a phosphatase to produce a detectable species; (c) detecting the detectable species; and (d) characterizing the nucleic acid sample based on such detection.
    Type: Grant
    Filed: August 29, 2003
    Date of Patent: July 14, 2009
    Assignee: GE Healthcare Bio-Sciences Corp.
    Inventors: Anup Sood, Shiv Kumar, Carl Fuller, John Nelson, John Macklin
  • Patent number: 7553658
    Abstract: The present invention is a method for the purification of plasmid DNA comprising to provide a composition comprising a first polymer having inverse solubility characteristics and a second polymer immiscible in the first polymer; contacting said solution with an aqueous solution comprising plasmid DNA; providing phase separation and isolating the aqueous phase; and increasing the temperature of the isolated phase to a temperature above the cloud point of the first polymer and below the temperature where plasmid DNA is degraded and subsequently isolating the aqueous phase so formed. The invention also encompasses a kit for purification of plasmid DNA as described above.
    Type: Grant
    Filed: June 17, 2003
    Date of Patent: June 30, 2009
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Cecilia Jansson Kepka, Jenny Rhodin Edsō, Folke Tjerneld
  • Patent number: 7552013
    Abstract: Disclosed herein are methods of selecting probes to target nucleic acid sequences, methods of making oligonucleotide arrays comprising such probes, and methods of using such arrays. Also, described herein are oligonucleotide arrays comprising probes selected by a method of the invention.
    Type: Grant
    Filed: March 15, 2006
    Date of Patent: June 23, 2009
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: David Dorris, Abhijit Mazumder, Richard D. Shippy
  • Patent number: 7534345
    Abstract: A chromatography column distribution system (101) comprises a set of first bed support ribs (107) extending radially from a inner, first radial position (R1) near the centre of the plate to a outer radial position nearer to the periphery (109) of the plate and at least one set of intermediate bed support ribs (117, 119) starting at an intermediate radial position (R2, R3) and extending to an outer radial position nearer to the periphery (109) of the plate (101), whereby channels are formed between adjacent bed support ribs (107, 117, 119).
    Type: Grant
    Filed: September 22, 2004
    Date of Patent: May 19, 2009
    Assignee: GE Healthcare Bio-Sciences AB
    Inventor: Klaus Gebauer
  • Patent number: 7527940
    Abstract: Disclosed is method for measuring a change in a cellular morphological parameter, for example, the position and/or the shape of a cell. The method comprises labelling a population of cells with a marker substance which is in a non-detectable state, but which may be caused to become detectable by exposure to light of a suitable first wavelength. By exposing a sub-population of labelled cells to light of an appropriate first wavelength in a predetermined pattern, the sub-population of cells may be defined in which the area covered by the sub-population conforms to the pattern of illumination used. Subsequent examination of at least a portion of the population of cells using illuminating light of a second wavelength selected to be suitable for detection of the marker, will reveal patterns of distribution of the marker substance indicative of a change in said cellular morphological parameter.
    Type: Grant
    Filed: May 7, 2003
    Date of Patent: May 5, 2009
    Assignee: GE Healthcare UK Limited
    Inventor: Nicholas Thomas
  • Patent number: 7510657
    Abstract: The present invention is a method of preparing affinity ligands, which method comprises to provide a cyclic scaffold comprising a thiol group, a carbonyl group and an amine group; to derivatize the amine group of said scaffold with an electrophile that carries either a functionality capable of affinity interaction or a functionality capable of a second interaction with a target molecule; and to open up the derivatized scaffold and add an amine that carries either a functionality capable of a second interaction or a functionality capable of affinity interaction with a target molecule. The method provides provide affinity ligands, which are capable of affinity interaction as well as a second kind of interaction.
    Type: Grant
    Filed: March 5, 2004
    Date of Patent: March 31, 2009
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Jean-Luc Maloisel, Nicolas Thevenin
  • Patent number: 7511155
    Abstract: A matched set of fluorescent dyes is provided, wherein each dye of the set is capable of covalent attachment to a protein and wherein each of the dyes has a molecular structure and a charge that is matched one with the other, such that relative electrophoretic mobility of a protein labeled with one dye of the set is the same as the electrophoretic mobility of the protein labeled with a different dye of the set. The matched set comprises at least two different fluorescent dyes of formula: wherein n is 1, 2, or 3; Z1 and Z2 independently represent the carbon atoms necessary to complete a phenyl or naphthyl ring system; one of groups R1 and R2 is a target bonding group; remaining group R1 or R2 is selected from —(CH2)4—W or —(CH2)r—H; group R3 is hydrogen, except when either R1 or R2 is —(CH2)r—H, in which case R3 is W; and W is selected from sulphonic acid and sulphonate.
    Type: Grant
    Filed: July 8, 2002
    Date of Patent: March 31, 2009
    Assignee: GE Healthcare UK Limited
    Inventors: Karen Williams, Timothy Stone, Adrian Christopher Simmonds, Alison Claire Sweet, Susan Janet Fowler
  • Patent number: 7470350
    Abstract: A process for light water detritiation which includes the steps of water distillation for tritium stripping and enriching, followed by chemical conversion of tritium enriched water to elemental hydrogen, and finally by one or more thermal diffusion columns for final tritium enrichment. The combination of process steps takes advantage of water distillation large throughput capability at low tritium concentration with the simplicity of thermal diffusion for small throughput final tritium enrichment. The water distillation front-end and the thermal diffusion back end processes are compatible with any intermediate chemical conversion process such as electrolysis or water gas shift reaction to convert tritiated water to elemental hydrogen.
    Type: Grant
    Filed: April 20, 2007
    Date of Patent: December 30, 2008
    Assignee: GE Healthcare UK Limited
    Inventors: Ian Richard Bonnett, Anthony Busigin
  • Patent number: 7452698
    Abstract: The present invention describes terminal phosphate blocked nucleoside polyphosphates that are stable at high temperature and their use in nucleic acid amplification and analysis. Current invention further describes charge modified terminal phosphate blocked nucleoside polyphosphates for improved incorporation and direct loading of nucleic acid sequencing reactions onto separating media.
    Type: Grant
    Filed: July 24, 2007
    Date of Patent: November 18, 2008
    Assignee: GE Healthcare Bio-Sciences Corp.
    Inventors: Anup Sood, Shiv Kumar, Carl W. Fuller, John R. Nelson
  • Patent number: 7445902
    Abstract: The present invention provides fluorescent cyanine dye-based nucleotide analogues, in which the cyanine dye is coupled to the ?-phosphate group of a nucleoside triphosphate. Preferred embodiments of the invention are directed to fluorescent cyanine dye-based GTP analogues which may be employed in an homogeneous FRET-based assay to measure the binding of guanine nucleotides to GPCR polypeptides, or alternatively, to measure the effect of an exogenous ligand on GPCR protein binding.
    Type: Grant
    Filed: September 27, 2005
    Date of Patent: November 4, 2008
    Assignee: GE Healthcare UK Limited
    Inventors: Mark Samuel Briggs, John Anthony Smith, Albert Francis Santos
  • Patent number: 7423070
    Abstract: The present invention is a surface-modified base matrix comprised of a porous polymeric base matrix onto which branched hydrophilic polyhydroxy-functional polymers have been covalently attached, wherein the polyhydroxy-functional polymers are hyperbranched polymers presenting a degree of branching (DB) of at least about 0.2 and each polymer is tethered to the base matrix at two or more points. The present matrix can for example be a cross-linked carbohydrate material, such as agarose, and the hyperbranched hydrophilic polymer can e.g. be a copolymer of epichiorohydrin and a sugar. The invention also relates to a method of surface-modification of a porous base matrix by activating functional hydroxy groups thereon and contacting the activated matrix with a hydrophilic hyperbranched hydroxy-functional polymer.
    Type: Grant
    Filed: June 18, 2003
    Date of Patent: September 9, 2008
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Anders Larsson, Ulrika Meyer, Kajsa Stridsberg Fridén, Eva Von Heijne
  • Patent number: 7423124
    Abstract: The present invention is a method of purifying recombinant human serum albumin (rHSA) from a solution, which method comprises to subject a cell culture supernatant (CCS) comprising rHSA cation exchange on a bimodal high salt tolerant matrix; hydrophobic interaction chromatography (HIC); anion exchange; and recovering the purified rHSA. The bimodal high salt tolerant cation exchange matrix used enables performing a purification of a cell culture supernatant directly, in the sense that no further dilution thereof is necessary. Due to its high binding capacity, said bimodal cation exchange matrix also allows use of a smaller amount of matrix as compared to a corresponding conventional cation exchanger matrix. Accordingly, the present invention allows substantial savings as regards volumes and consequently operation costs.
    Type: Grant
    Filed: May 9, 2003
    Date of Patent: September 9, 2008
    Assignee: Ge Healthcare Bio-Sciences AB
    Inventors: Makonnen Belew, Mei Yan Li, Wei Zhang
  • Patent number: 7402654
    Abstract: A purified recombinant DNA polymerase having high processivity and strand-displacement activity. An isolated nucleic acid that encodes the bacteriophage DNA polymerase. A kit and method for amplifying DNA is also disclosed.
    Type: Grant
    Filed: December 22, 2005
    Date of Patent: July 22, 2008
    Assignee: GE Healthcare Bio-Sciences Corp.
    Inventors: Carl W. Fuller, Cuong Lam
  • Patent number: 7396467
    Abstract: The present invention relates to a method of preparing a porous cross-linked polysaccharide chromatography matrix, which comprises to provide an aqueous solution of a gellable polysaccharide, wherein part of the hydroxyl groups are substituted with groups which are not susceptible to nucleophilic attack; to provide essentially spherical droplets of the substituted polysaccharide solution; to form a gel of the substituted polysaccharide solution; and to cross-link the gel by adding a cross-linking agent. The invention also encompasses a chromatography column packed with a matrix so produced as well as use thereof in e.g. protein purification.
    Type: Grant
    Filed: October 13, 2004
    Date of Patent: July 8, 2008
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Hans Berg, David Buckley, Maria Brännholm, Anders Hagvall, Henrik Ihre, Eva Holmgren, Anders Larsson, Dag Lindstrom
  • Patent number: D576169
    Type: Grant
    Filed: July 18, 2005
    Date of Patent: September 2, 2008
    Assignee: GE Healthcare Bio-Sciences AB
    Inventor: Malin Soderstrom
  • Patent number: D595423
    Type: Grant
    Filed: December 10, 2008
    Date of Patent: June 30, 2009
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Bjorn A. Johansson, Nils Norrman, Henrik Ostlin, Sven Wounder
  • Patent number: D597217
    Type: Grant
    Filed: March 27, 2008
    Date of Patent: July 28, 2009
    Assignee: GE Healthcare Bio-Sciences AB
    Inventor: Sven Wounder